Sign in to continue:

Thursday, February 5th, 2026

Category: IPO

All News on IPO

Bursa KLSE stocksIPO

Wasco Greenergy Berhad IPO Application Guide 2025 – Step-by-Step Procedures, Eligibility & Key Dates 1

minichart
December 6, 2025

Wasco Greenergy Berhad IPO Analysis: Comprehensive Investor Guide Company: Wasco Greenergy Berhad Date of Prospectus: 20 November 2025 Wasco Greenergy Berhad IPO: In-Depth Analysis, Offer Structure, and Listing Outlook for Investors Wasco Greenergy Berhad...

Continue Reading 0
Bursa KLSE stocksIPO

LAC Med Berhad IPO Prospectus 2025: Key Financials, Risks, and Growth Opportunities Explained

minichart
December 6, 2025

LAC Med Berhad IPO: Comprehensive Investor Analysis, Offer Details, Financials, and Outlook Company Name: LAC Med Berhad Date of Prospectus: 14 November 2025 LAC Med Berhad IPO: In-Depth Analysis, Financials, and Investor Outlook Malaysia’s...

Continue Reading 0
Bursa KLSE stocksIPO

Leading Medical Device Distributor LAC Medical Berhad Announces IPO on Bursa Malaysia – Innovative EaaS & MEAMS Expansion Plans 252627149

minichart
December 6, 2025

LAC Med Berhad IPO Analysis: Growth, Financials, Risks, and Listing Outlook LAC Med Berhad Date of Prospectus: 14 November 2025 LAC Med Berhad IPO: Growth-Driven Healthcare Play Targets Main Market Listing with Robust Financials...

Continue Reading 0
Bursa KLSE stocksIPO

How to Apply for LAC Med Berhad IPO Shares in Malaysia: Step-by-Step Guide, Eligibility & Bank List 1

minichart
December 6, 2025

LAC Med Berhad IPO: Comprehensive Investor Analysis, Offer Details & Outlook – November 2025 Company: LAC Med Berhad Date of Prospectus: 14 November 2025 LAC Med Berhad IPO: In-Depth Investment Analysis, Offer Details &...

Continue Reading 0
IPOSingapore SGX stocks

Leong Guan Holdings IPO: Singapore’s Leading Noodle Manufacturer Expands with Technology-Driven Growth and Employee Share Option Scheme

minichart
December 6, 2025

Leong Guan Holdings Limited IPO: Comprehensive Investor Analysis Leong Guan Holdings Limited Date of Prospectus: 28 November 2025 Leong Guan Holdings IPO: Deep Dive Into Singapore’s Leading Noodle Manufacturer’s 2025 Catalist Listing Leong Guan...

Continue Reading 0
Hong Kong stocksIPOMarket Updates

JD.com’s supply-chain technology arm, Jingdong Industrials, has begun taking investor orders for its Hong Kong initial public offering (IPO), aiming to raise up to HK$3.3 billion (S$549 million).

minichart
December 3, 2025

JD.com’s supply-chain technology arm, Jingdong Industrials, has begun taking investor orders for its Hong Kong initial public offering (IPO), aiming to raise up to HK$3.3 billion (S$549 million). The move caps more than two...

Continue Reading 0

Infinity Development Holdings IPO

IPOMarket UpdatesSingapore SGX stocks
Ming Lun
November 28, 2025

Infinity Development Holdings is conducting an all-placement IPO on the Singapore Exchange’s (SGX) Catalist board, with trading set to begin on December 3, 2025. The Hong Kong-based adhesives manufacturer aims to raise S$11.1 million...

Continue Reading 0
IPO

Financial Analysis Report

minichart
October 11, 2025

Beijing Yunji Technology Co., Ltd. IPO Analysis: Deep Dive for Investors Company Name: Beijing Yunji Technology Co., Ltd. Date of Prospectus: October 8, 2025 Beijing Yunji Technology Co., Ltd. Hong Kong IPO: Full Analysis,...

Continue Reading 0
IPO

Xuanzhu Biopharma IPO: Innovative Drug Pipeline, Commercialization Strategy, and Competitive Advantages in China’s Pharmaceutical Market

minichart
October 11, 2025

Xuanzhu Biopharma IPO Analysis: Offer Details, Financials, Risks, and Outlook (October 2025) Xuanzhu Biopharma Date of Prospectus: October 6, 2025 Xuanzhu Biopharma Launches Hong Kong IPO: In-Depth Analysis of Offer Structure, Financials, Growth Prospects,...

Continue Reading 0
IPO

Fujian Haixi Pharmaceuticals IPO: Innovative Drug Pipeline, Market Position & Growth Strategies Explained

minichart
October 11, 2025

HX Pharma IPO: Comprehensive Investor Analysis – October 2025 HX Pharma Date of Prospectus: October 9, 2025 Bold Bet on Future Growth: HX Pharma’s Landmark Hong Kong IPO Targets R&D, Innovation, and Market Expansion...

Continue Reading 0